loadpatents
name:-0.025422096252441
name:-0.013490915298462
name:-0.0079679489135742
Reusch; Uwe Patent Filings

Reusch; Uwe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Reusch; Uwe.The latest application filed is for "trifunctional antigen-binding molecule".

Company Profile
9.16.27
  • Reusch; Uwe - Maikammer DE
  • Reusch; Uwe - Heidelberg DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Trifunctional Antigen-binding Molecule
App 20220048994 - Little; Melvyn ;   et al.
2022-02-17
Tandem Diabody for CD16A-directed NK-cell Engagement
App 20220041717 - ROSS; Thorsten ;   et al.
2022-02-10
Tandem diabody for CD16A-directed NK-cell engagement
Grant 11,180,558 - Ross , et al. November 23, 2
2021-11-23
Combination of a CD30XCD16 antibody with a PD-1 antagonist for therapy
Grant 11,167,029 - Treder , et al. November 9, 2
2021-11-09
Uses Of Nk Cell Engaging Antibody Fusion Constructs For Treatments
App 20210253698 - Tesar; Michael ;   et al.
2021-08-19
Cryopreserved NK cells preloaded with an antibody construct
App 20210169936 - REUSCH; Uwe ;   et al.
2021-06-10
NK cell engaging antibody fusion constructs
Grant 11,001,633 - Tesar , et al. May 11, 2
2021-05-11
Bispecific CD33 and CD3 Binding Proteins
App 20210024654 - Ellwanger; Kristina ;   et al.
2021-01-28
Bispecific Egfr/cd16 Antigen-binding Protein
App 20200405833 - Kluge; Michael ;   et al.
2020-12-31
Bispecific CD33 and CD3 binding proteins
Grant 10,626,190 - Ellwanger , et al.
2020-04-21
Nk Cell Engaging Antibody Fusion Constructs
App 20200109202 - Tesar; Michael ;   et al.
2020-04-09
Combination Of An Anti-cd16a Antibody With A Cytokine
App 20200010547 - Koch; Joachim ;   et al.
2020-01-09
Tandem Diabody for CD16A-directed NK-cell Engagement
App 20190345249 - Ross; Thorsten ;   et al.
2019-11-14
Antibody binding sites specific for EGFRvIII
Grant 10,273,309 - Ellwanger , et al.
2019-04-30
Multivalent Fv Antibodies
App 20190040155 - ELLWANGER; Kristina ;   et al.
2019-02-07
Bispecific CD33 and CD3 Binding Proteins
App 20180291113 - ELLWANGER; Kristina ;   et al.
2018-10-11
CD3 binding domains
Grant 10,066,015 - Zhukovsky , et al. September 4, 2
2018-09-04
Combination Of A Cd30xcd16 Antibody With A Pd-1 Antagonist For Therapy
App 20180085456 - TREDER; Martin ;   et al.
2018-03-29
Bispecific CD33 and CD3 binding proteins
Grant 9,803,029 - Ellwanger , et al. October 31, 2
2017-10-31
Anti-CD16 binding molecules
Grant 9,701,750 - Hoffmann , et al. July 11, 2
2017-07-11
Trifunctional Antigen-binding Molecule
App 20170037128 - LITTLE; Melvyn ;   et al.
2017-02-09
Compounds For Use In The Treatment Of Alzheimer's Disease
App 20160361413 - Weiss; Stefan Franz Thomas ;   et al.
2016-12-15
Bispecific CD33 and CD3 Binding Proteins
App 20160194409 - ELLWANGER; Kristina ;   et al.
2016-07-07
Compounds for use in the treatment of Alzheimer's disease
Grant 9,365,647 - Weiss , et al. June 14, 2
2016-06-14
ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII
App 20160152728 - ELLWANGER; Kristina ;   et al.
2016-06-02
Cd3 Binding Domains
App 20160039934 - ZHUKOVSKY; Eugene ;   et al.
2016-02-11
Bispecific CD33 and CD3 Binding Proteins
App 20160002333 - ELLWANGER; Kristina ;   et al.
2016-01-07
Human CD3-specific antibody with immunosuppressive properties
Grant 9,226,962 - Le Gall , et al. January 5, 2
2016-01-05
Bispecific CD33 and CD3 binding proteins
Grant 9,212,225 - Ellwanger , et al. December 15, 2
2015-12-15
Anti-cd16 Binding Molecules
App 20150218275 - Hoffmann; Karin ;   et al.
2015-08-06
Anti-CD16 binding molecules
Grant 9,035,026 - Hoffmann , et al. May 19, 2
2015-05-19
Compounds For Use In The Treatment Of Alzheimer's Disease
App 20140220041 - Weiss; Stefan Franz Thomas ;   et al.
2014-08-07
Human Cd3-specific Antibody With Immunosuppressive Properties
App 20130115213 - LE GALL; Fabrice ;   et al.
2013-05-09
Use of an antibody against the laminin receptor or laminin receptor precursor for the treatment or diagnosis of several cancer types
Grant 7,901,677 - Little , et al. March 8, 2
2011-03-08
Anti-cd16 binding molecules
App 20090214574 - Hoffmann; Karin ;   et al.
2009-08-27
Single-chain antibody acting against 37 kDa/67 kDa Iaminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof
Grant 7,507,797 - Knackmuss , et al. March 24, 2
2009-03-24
Single-chain antibody acting against 37 kda/67 kda laminin receptor as tools for the diagnosis and therapy of prion diseases and cancer, production and use thereof
App 20070041977 - Knackmuss; Stefan ;   et al.
2007-02-22
Human cd3-specific antibody with immunosuppressive properties
App 20060233787 - Le Gall; Fabrice ;   et al.
2006-10-19
Dimeric and multimeric antigen binding structure
App 20050079170 - Le Gall, Fabrice ;   et al.
2005-04-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed